Intermittent Fasting Attenuates Obesity-Induced Triple-Negative Breast Cancer Progression by Disrupting Cell Cycle, Epithelial–Mesenchymal Transition, Immune Contexture, and Proinflammatory Signature
Nutrients · 2024
DOI: 10.3390/nu16132101 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Nutrients, 2024. Verfasst von Deok-Soo Son und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, School of Medicine, Meharry Medical College, Nashville, TN 37208, USA. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Obesity, Epithelial-Mesenchymal Transition, Disease Progression. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, NIMHD NIH HHS.
Abstract (Originalsprache)
Obesity is associated with one-fifth of cancer deaths, and breast cancer is one of the obesity-related cancers. Triple-negative breast cancer (TNBC) lacks estrogen and progesterone receptors and human epidermal growth factor receptor 2, leading to the absence of these therapeutic targets, followed by poor overall survival. We investigated if obesity could hasten TNBC progression and intermittent fasting (IF) could attenuate the progression of obesity-related TNBC. Our meta-analysis of the TNBC outcomes literature showed that obesity led to poorer overall survival in TNBC patients. Fasting-mimicking media reduced cell proliferation disrupted the cell cycle, and decreased cell migration and invasion. IF decreased body weight in obese mice but no change in normal mice. Obese mice exhibited elevated plasma glucose and cholesterol levels, increased tumor volume and weight, and enhanced macrophage accumulation in tumors. The obesity-exacerbated TNBC progression was attenuated after IF, which decreased cyclin B1 and vimentin levels and reduced the proinflammatory signature in the obesity-associated tumor microenvironment. IF attenuated obesity-induced TNBC progression through reduced obesity and tumor burdens in cell and animal experiments, supporting the potential of a cost-effective adjuvant IF therapy for TNBC through lifestyle change. Further evidence is needed of these IF benefits in TNBC, including from human clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, School of Medicine, Meharry Medical College, Nashville, TN 37208, USA.
- Biochemistry Program, College of Arts and Sciences, Spelman College, Atlanta, GA 30314, USA.
- Neuroscience Program, College of Arts and Sciences, The University of Tennessee, Knoxville, TN 37996, USA.
- Pathology, Anatomy and Cell Biology, Meharry Medical College, Nashville, TN 37208, USA.
- Animal Core Facility, Meharry Medical College, Nashville, TN 37208, USA.
- Department of Pharmaceutical Sciences, College of Pharmacy, Florida A&M University, Tallahassee, FL 32301, USA.
ORCID-Profile: Eun-Sook Lee
Förderung
- NCI NIH HHS
- NIH HHS
- NIMHD NIH HHS
- NIEHS NIH HHS
- ACS
- National Institutes of Health (NIH)
Zitieren
APA
Son, D. S., Done, K. A., Son, J., Izban, M. G., Virgous, C., Lee, E. S., & Adunyah, S. E. (2024). Intermittent Fasting Attenuates Obesity-Induced Triple-Negative Breast Cancer Progression by Disrupting Cell Cycle, Epithelial–Mesenchymal Transition, Immune Contexture, and Proinflammatory Signature. Nutrients. https://doi.org/10.3390/nu16132101
Vancouver
Son DS, Done KA, Son J, Izban MG, Virgous C, Lee ES, et al. Intermittent Fasting Attenuates Obesity-Induced Triple-Negative Breast Cancer Progression by Disrupting Cell Cycle, Epithelial–Mesenchymal Transition, Immune Contexture, and Proinflammatory Signature. Nutrients. 2024. doi:10.3390/nu16132101
BibTeX
@article{Son2024,
author = {Son, Deok-Soo and Done, Kaitlyn A and Son, Jubin and Izban, Michael G and Virgous, Carlos and Lee, Eun-Sook and Adunyah, Samuel E},
title = {Intermittent Fasting Attenuates Obesity-Induced Triple-Negative Breast Cancer Progression by Disrupting Cell Cycle, Epithelial–Mesenchymal Transition, Immune Contexture, and Proinflammatory Signature},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16132101}
}
EUVIMED